Tony Taldone is a Senior Project Manager, Drug Development in the Office of Technology Development. He manages small molecule drug development projects. He joined OTD as a Senior Project Manager, Drug Development in April/2022.  

Tony’s prior experience include as a Scientific Advisor at Amster Rothstein & Ebenstein, LLP, a New York based intellectual property law firm, where he assisted in the preparation and prosecution of patent applications. Prior to that, Tony was a Senior Research Scientist at MSKCC, working on the discovery and development of small molecule inhibitors targeting the epichaperome for the treatment of cancer and neurodegenerative diseases.

Tony graduated from St. John’s University with a Doctor of Philosophy degree in Pharmaceutical Sciences with a focus in Medicinal Chemistry.